The 3' Region of the Chicken Hypersensitive Site-4 Insulator Has Properties Similar to Its Core and is Required for Full Insulator Activity
Overview
Authors
Affiliations
Chromatin insulators separate active transcriptional domains and block the spread of heterochromatin in the genome. Studies on the chicken hypersensitive site-4 (cHS4) element, a prototypic insulator, have identified CTCF and USF-1/2 motifs in the proximal 250 bp of cHS4, termed the "core", which provide enhancer blocking activity and reduce position effects. However, the core alone does not insulate viral vectors effectively. The full-length cHS4 has excellent insulating properties, but its large size severely compromises vector titers. We performed a structure-function analysis of cHS4 flanking lentivirus-vectors and analyzed transgene expression in the clonal progeny of hematopoietic stem cells and epigenetic changes in cHS4 and the transgene promoter. We found that the core only reduced the clonal variegation in expression. Unique insulator activity resided in the distal 400 bp cHS4 sequences, which when combined with the core, restored full insulator activity and open chromatin marks over the transgene promoter and the insulator. These data consolidate the known insulating activity of the canonical 5' core with a novel 3' 400 bp element with properties similar to the core. Together, they have excellent insulating properties and viral titers. Our data have important implications in understanding the molecular basis of insulator function and design of gene therapy vectors.
Lentiviral-Mediated Systemic RNA Interference In Vivo.
Liu S Methods Mol Biol. 2024; 2766:153-161.
PMID: 38270875 DOI: 10.1007/978-1-0716-3682-4_16.
Tristan-Manzano M, Maldonado-Perez N, Justicia-Lirio P, Cortijo-Gutierrez M, Tristan-Ramos P, Blanco-Benitez C Mol Ther Nucleic Acids. 2023; 32:322-339.
PMID: 37125150 PMC: 10141506. DOI: 10.1016/j.omtn.2023.03.018.
Cortijo-Gutierrez M, Sanchez-Hernandez S, Tristan-Manzano M, Maldonado-Perez N, Lopez-Onieva L, Real P Pharmaceutics. 2021; 13(8).
PMID: 34452178 PMC: 8401568. DOI: 10.3390/pharmaceutics13081217.
Gene Therapy For Beta-Thalassemia: Updated Perspectives.
Karponi G, Zogas N Appl Clin Genet. 2019; 12:167-180.
PMID: 31576160 PMC: 6765258. DOI: 10.2147/TACG.S178546.
Arumugam P, Suzuki T, Shima K, McCarthy C, Sallese A, Wessendarp M Mol Ther. 2019; 27(9):1597-1611.
PMID: 31326401 PMC: 6731469. DOI: 10.1016/j.ymthe.2019.06.010.